Amarin Corp Plc (AMRN)

[Number sleven]

TTE, I agree that this would be an important trial, if successful. The phase 2 trial that I just posted could serve to change the recent sentiment. I find it interesting that the preclinical studies have triggered this much interest in Icosapent ethyl for the treatment of cancer. Take a close look at the BRAVE study. All of the primary and secondary endpoints have already been achieved in studies on mice. The study conducted by the VA is extremely invasive. It has a DMC. I assume if the data collected to this point wasn't trending positive, the study would have been halted.
Sleven,